longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Q2 Earnings Surge: Rivian and Vicor Lead as Revenue Growth Defies Macro Drag

Global Report
Sep 8, 2026 at 09:18 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Second-quarter financials across the EV, semi-cap, and consumer sectors show robust top-line momentum. Rivian raised its EBITDA outlook, while hardware makers like Vicor capitalized on AI tailwinds with massive revenue jumps.

A wave of second-quarter earnings reports is revealing resilient top-line growth across disparate sectors, with companies leveraging strong underlying demand to revise forward guidance upward. The 2026 data points to a market environment where fundamental execution is heavily rewarding top-tier players.

In the hardware and EV spaces, Rivian Automotive (RIVN.US) posted a 27.2% year-over-year revenue jump to $1.66 billion, trimming losses and raising its full-year adjusted EBITDA forecast. Capitalizing on AI data center buildouts, Vicor (VICR.US) saw total net revenues surge 49.3% to $143.4 million, driving a 26% sequential expansion in backlog to $379.7 million. ACM Research (ACMR.US) mirrored this momentum in the semiconductor equipment segment, growing revenue by 36% to $292.9 million and lifting its annual target to as much as $1.175 billion. Meanwhile, specialty materials producer ATI (ATI.US) delivered $1.26 billion in sales and logged a record $4.4 billion order backlog.

Consumer and healthcare metrics also underscore operational efficiency. Crocs (CROX.US) reported $1.18 billion in quarterly revenue, yielding an EPS of $4.55 that easily cleared analyst estimates. Dingdong (DDL.US) expanded its GMV by 11.8% to 7.26 billion yuan, paired with a massive 153.5% surge in net income. In biotech, Legend Biotech (LEGN.US) generated $387.5 million in total revenue alongside a $57.7 million operating profit. Conversely, AI-driven drug discovery firm Absci (ABSI.US) increased its R&D spend to accelerate its pipeline, widening net losses to $33.2 million.

On the tactical trading front, volatility funds like the Simplify Volatility Premium ETF (SVOL.US) and VSXY (VSXY.US) remain active instruments for institutional hedging, with SVOL maintaining a 17.5% one-year return as investors navigate shifting macro conditions.

Login to unlock1,341characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Mar 19, 2026 at 01:37 PMThe three major U.S. stock indices opened lower collectively, and precious metal concept stocks fell sharply

Related Stocks

Rivian Automotive

Rivian Automotive

USRIVN

-0.12%

Vicor

Vicor

USVICR

+11.15%

ACM Research

ACM Research

USACMR

-0.54%

LongbridgeAI